Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

202213 citationsJournal Articlegold Open Access

Authors

Our results suggest that C/T is a safe and effective therapeutic regimen for patients with MDR and XDR P. aeruginosa LRTI.

Good health and well-being

Published in: Infectious Diseases and Therapy

Volume 11, Issue 5, pp. 1965-1980

Field-Weighted Citation Impact: 0.94